Search results
AstraZeneca posts mixed results from recent Imfinzi trials
ShareCast· 1 day agoAstraZeneca announced contrasting results from two phase three trials involving its immunotherapy...
AstraZeneca disappointed with failure of immunotherapy in early-stage lung cancer
Proactive Financial News· 1 day agoAstraZeneca PLC (LSE:AZN) shared some disappointing news on an advanced lung cancer trial of its...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters via Yahoo Finance UK· 11 hours agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer...
Benzinga via Yahoo Finance UK· 4 hours agoOn Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition...
TOP NEWS: AstraZeneca details mixed findings from cancer drug trials
Morningstar· 1 day agoShares in AstraZeneca rose 0.6% to 12,548.00 pence on Tuesday morning. The Cambridge-based pharmaceutical company said Imfinzi met both its primary and secondary aims in a trial on sufferers of bladder cancer.
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance UK· 1 day agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 1 day agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks via Yahoo Finance UK· 6 days agoThe European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for...
AstraZeneca announces positive bladder cancer trial results, Landsec raises Bluewater stake
ShareCast· 1 day agoThe FTSE 100 is expected to open 13 points lower on Tuesday, having closed up 0.53% on Monday at 8,281.55. AstraZeneca announced on Tuesday that a recent trial revealed that ...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance UK· 6 hours agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...